Recommended shielding against SARS-CoV-2 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis

E. Hatziagorou (Thessaloniki, Greece), I. Toulia (Thessaloniki, Greece), P. Peftoulidou (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), E. Tasika (Thessaloniki, Greece), E. Chrysochoou (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece)

Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Session: Cystic fibrosis in children: various aspects
Session type: E-poster
Number: 3371

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Hatziagorou (Thessaloniki, Greece), I. Toulia (Thessaloniki, Greece), P. Peftoulidou (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), E. Tasika (Thessaloniki, Greece), E. Chrysochoou (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece). Recommended shielding against SARS-CoV-2 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis. 3371

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis
Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016
Year: 2017



Assessment of Lumacaftor/Ivacaftor therapy on physical activity and exercise tolerance in adults with cystic fibrosis
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Effect of home intravenous antibiotic treatment on exercise capacity in children with cystic fibrosis
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010


Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001

Relationships between bronchodilator therapy, resting energy expenditure and systemic inflammation in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003

Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Factors affecting the compliance to antifibrotic treatment in patients with interstitial pulmonary fibrosis
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006


Comparison of exercise capacity, physical activity level and quality of life in patients with different severity of non-cystic fibrosis bronchiectasis>
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021


Changes in mechanical properties of respiratory system in children with cystic fibrosis during therapy of exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 612s
Year: 2005

Increase motivation and efficiecy in cystic fibrosis teenagers using sport activities, respiratory muscle training and airway clearance techniques
Source: Annual Congress 2012 - The latest insights in chronic care
Year: 2012


Correlation of physical fitness with peripheral muscle strength, physical activity levels and lung function in patients with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis
Source: Eur Respir J 2014; 43: 817-823
Year: 2014



Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF)
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019


The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Year: 2021



Lack of therapeutic potential for topical metformin in treatment of airway secretion dehydration in cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021
Year: 2021



The effect of lung volume reduction on the success of physical activity coaching in patients with severe COPD
Source: Virtual Congress 2020 – Physical activity and chronic lung disease: once a new kid, now growing up
Year: 2020




Airway clearance techniques, pulmonary rehabilitation and physical activity
Source: Eur Respir Monogr 2018; 81: 331-352
Year: 2018